Dexus owns and manages Australia's largest portfolio of premium office buildings, complemented by industrial and healthcare real estate. It earns income from two sources: rent on directly owned properties and management fees from $36.2 billion in third-party funds — a dual-engine model that amplifies both recovery potential and near-term earnings volatility.
The most recent half-year results showed underlying funds from operations of $311 million. Strip out $40.9 million in one-off trading profits and recurring earnings were declining 7.6% year-on-year. The portfolio itself is performing well: office occupancy climbed to 92.2% against a market average of 85.7%, leasing volumes doubled, and industrial rents on expiring leases settled 8.9% above prior passing rates.
The investment case rests on a straightforward disconnect. Independent valuers have appraised Dexus's assets at $8.95 per security. The market pays $6.59. That 26% gap is the widest in the peer group. The complication is FY27, when trading profits and performance fees normalise — a $95 million combined headwind — pushing AFFO down 16%. Investors carry a 5.6% income yield while waiting for industrial reversion and office stabilisation to close the gap.
At A$6.59 versus fair value of A$7.59, the stock is undervalued by 15%.